 CAMBRIDGE, Mass.--BUSINESS WIRE--Sage Therapeutics, Inc. Nasdaq: SAGE, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Thursday, February 24, 2022 at 8:00 a.m. ET to announce fourth quarter and full year 2021 financial results and discuss recent business updates. The webcast can be accessed on the investor page of Sages website at 